Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] · 2025
What's New With Under Eye Treatment: A Multispecialty Systematic Review of Recent Under Eye Treatments.
Систематический обзорСтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Beer Jacob, Boghosian Tanya, Sherif Rami, Montes Jose, Tosti Antonella, Rohrich Rod, Beer Kenneth
Аннотация
BACKGROUND: Infraorbital hollowing and hyperpigmentation are common cosmetic concerns resulting from structural volume loss, pigmentary changes, vascular prominence, and skin laxity.
OBJECTIVE: To systematically review current and emerging treatments for infraorbital concerns with an emphasis on patient selection and anatomy-driven approaches.
MATERIALS AND METHODS: A systematic PubMed search was conducted in March 2025 per Preferred Reporting Items for Systematic Reviews and Meta-analyses guidelines for English-language studies published after 2010. Fifty studies were selected and categorized by treatment type. Each modality was evaluated for efficacy, safety, and patient suitability.
RESULTS: Treatments were organized into injectables, energy-based devices, microneedling, peels, topicals, polynucleotides, platelet-rich plasma/platelet-rich fibrin, neuromodulators, and surgery. Fillers remain foundational for volume loss; lasers address melanin, vascularity, and skin laxity. Microneedling and polynucleotides target texture and fine rhytides. Chemical peels and topicals are effective for superficial dyschromia. Botulinum toxin benefits orbicularis oculi hypertrophy and sequelae. Surgery is preferred for herniated fat and poor lower eyelid support. Patient-specific factors, including fat pad integrity, skin quality, and eyelid support, are critical for optimal results.
CONCLUSION: Infraorbital concerns are multifactorial and require individualized treatment strategies. This review integrates evidence and clinical expertise to guide personalized, anatomy-driven interventions that optimize outcomes in periorbital rejuvenation.
OBJECTIVE: To systematically review current and emerging treatments for infraorbital concerns with an emphasis on patient selection and anatomy-driven approaches.
MATERIALS AND METHODS: A systematic PubMed search was conducted in March 2025 per Preferred Reporting Items for Systematic Reviews and Meta-analyses guidelines for English-language studies published after 2010. Fifty studies were selected and categorized by treatment type. Each modality was evaluated for efficacy, safety, and patient suitability.
RESULTS: Treatments were organized into injectables, energy-based devices, microneedling, peels, topicals, polynucleotides, platelet-rich plasma/platelet-rich fibrin, neuromodulators, and surgery. Fillers remain foundational for volume loss; lasers address melanin, vascularity, and skin laxity. Microneedling and polynucleotides target texture and fine rhytides. Chemical peels and topicals are effective for superficial dyschromia. Botulinum toxin benefits orbicularis oculi hypertrophy and sequelae. Surgery is preferred for herniated fat and poor lower eyelid support. Patient-specific factors, including fat pad integrity, skin quality, and eyelid support, are critical for optimal results.
CONCLUSION: Infraorbital concerns are multifactorial and require individualized treatment strategies. This review integrates evidence and clinical expertise to guide personalized, anatomy-driven interventions that optimize outcomes in periorbital rejuvenation.